DMT’s chemical structure, explained: one indole ring, a short chain and two methyl groups

THE SHORT VERSION · SWIPE

▶ Watch it as a 20-second video

‹›

DMT is a small molecule that shares a skeleton with a brain messenger (serotonin), a hormone (melatonin) and the active compound of magic mushrooms (psilocin). Below, we take the structure apart piece by piece, set it beside its relatives, and explain why one extra group of atoms can matter so much at a receptor. For where DMT occurs and what it does, see our pillar guide, what is DMT.

What is the chemical structure of dimethyltryptamine (DMT)?

PubChem, the US National Library of Medicine’s chemistry database, lists N,N-dimethyltryptamine as compound 6089, with the formula C12H16N2 (twelve carbons, sixteen hydrogens, two nitrogens and no oxygen), a molecular weight of 188.27 g/mol and the systematic (IUPAC) name 2-(1H-indol-3-yl)-N,N-dimethylethanamine (PubChem, DMT). Evidence: established.

Read left to right, that name says: an indole, attached at its 3-position to an ethanamine (a two-carbon chain ending in an amine nitrogen), with two methyl groups on that nitrogen. The table lists the identifiers chemists use to pin the molecule down.

What are the indole ring and the tryptamine family?

An indole is a pair of fused rings: a benzene ring and a five-membered pyrrole ring that contains one nitrogen. PubChem lists indole itself as C8H7N (PubChem, indole). The same ring system sits in the amino acid tryptophan, (2S)-2-amino-3-(1H-indol-3-yl)propanoic acid (PubChem, tryptophan), which is why compounds built on it are called indoles or indolealkylamines. Evidence: established.

Tryptamine, 2-(1H-indol-3-yl)ethanamine (C10H12N2), is the indole with a two-carbon chain ending in a bare amine nitrogen (PubChem, tryptamine). Every member of the tryptamine family keeps that core and varies what sits on the ring or the nitrogen. Add one methyl group to the nitrogen and you have N-methyltryptamine, C11H14N2 (PubChem, NMT); add a second and you have DMT. Evidence: established.

In mammals the textbook pathway runs in the same order, from tryptophan to tryptamine to N-methyltryptamine to DMT, though which enzyme adds the methyl groups is now debated (Barker, 2018); see INMT, the enzyme linked to DMT. A 2018 review calls DMT “the archetype for all indole-containing serotonergic psychedelics”, with its structure embedded within those of LSD and psilocybin (Cameron and Olson, 2018). Evidence: established for the structures; unresolved for the enzyme.

What does the N,N-dimethyl group do?

Chemically, the two methyl groups turn tryptamine’s primary amine (a nitrogen with two hydrogens) into a tertiary amine (a nitrogen with three carbon attachments and no hydrogens). That changes the molecule’s size around the nitrogen, how it shares charge and how greasy it is, all of which affect how it is handled in the body and how it sits in a receptor’s binding pocket. That is general chemistry rather than a DMT-specific finding; the next paragraphs give the measured examples.

One concrete consequence has been reported. The sigma-1 receptor’s recognised binding pattern includes an alkylamine core, and a 2009 study noted that this core is also found in DMT. In that study DMT bound sigma-1 receptors in cells and made normal mice more active but not mice lacking the receptor (Fontanilla et al., 2009). DMT needs far higher concentrations to act at sigma-1 than at the 5-HT2A receptor (Barker, 2018), so what this means in people is unclear. Evidence: preliminary. More in DMT and the sigma-1 receptor.

The same small molecule is cleared quickly. The enzyme monoamine oxidase A breaks DMT down mainly to indoleacetic acid, with DMT-N-oxide as the second most abundant product (Barker, 2018). Evidence: established. Why that matters is the subject of why DMT breaks down so fast.

How does DMT’s structure compare with serotonin, melatonin, psilocin and 5-MeO-DMT?

All five share the indole and the two-carbon chain. They differ in two places: what is on ring position 4 or 5, and what is on the chain’s nitrogen. The table sets them side by side from their PubChem records. It is a comparison of structure only; it implies nothing about effects.

DMT and serotonin

Serotonin is 3-(2-aminoethyl)-1H-indol-5-ol, C10H12N2O (PubChem, serotonin): the tryptamine skeleton with a hydroxyl group at ring position 5 and no methyls on the nitrogen. DMT is the reverse: no hydroxyl, two methyls. The family resemblance is part of why early research looked for a serotonin basis for psychedelic action, and classic psychedelics are now understood to act as agonists or partial agonists at serotonin 5-HT2A receptors (Nichols, 2016). Evidence: established.

DMT, psilocin and psilocybin

Psilocin is 3-[2-(dimethylamino)ethyl]-1H-indol-4-ol, C12H16N2O (PubChem, psilocin). In structural terms it is DMT with one hydroxyl group added at ring position 4, which is why chemists sometimes call it 4-hydroxy-DMT. Psilocybin carries a phosphate group at that position instead, C12H17N2O4P (PubChem, psilocybin); in the body it is primarily a prodrug, a compound the body converts into the active form, dephosphorylated by alkaline phosphatase to psilocin (Dinis-Oliveira, 2017). Evidence: established. Our article on psilocin vs psilocybin covers that step.

DMT and 5-MeO-DMT

5-MeO-DMT is 2-(5-methoxy-1H-indol-3-yl)-N,N-dimethylethanamine, C13H18N2O (PubChem, 5-MeO-DMT): DMT with a methoxy group (an oxygen bonded to a methyl) at ring position 5. That one group is enough to shift its receptor profile. A 2022 review describes 5-MeO-DMT as acting mainly at 5-HT1A and 5-HT2A receptors, with its highest affinity for 5-HT1A (Reckweg et al., 2022). Evidence: established for the structure; the full comparison is in 5-MeO-DMT vs DMT.

DMT and melatonin

Melatonin, the pineal gland’s hormone, is N-[2-(5-methoxy-1H-indol-3-yl)ethyl]acetamide, C13H16N2O2 (PubChem, melatonin). It shares the 5-methoxy group with 5-MeO-DMT, but its nitrogen carries an acetyl group, which makes it an amide rather than a basic amine. That is a bigger chemical change than it looks: melatonin is a close cousin on paper and a different kind of molecule in practice. Evidence: established.

The shared indole is one reason DMT and the pineal gland are so often mentioned together, but structure alone says nothing about where DMT is made. See is DMT in the pineal gland.

Why do small structural changes matter for receptors?

Receptors are proteins with pockets shaped to fit particular molecules. Structural biology now shows those pockets directly. In 2017 a team solved the crystal structure of LSD bound to the human serotonin 5-HT2B receptor and found that the receptor rearranges to accommodate LSD’s diethylamide group, with a “lid” over the pocket that may explain LSD’s slow binding (Wacker et al., 2017). Evidence: established.

In 2020 the active-state structure of the 5-HT2A receptor itself was solved, bound to a hallucinogen and its signalling partner, showing the rearrangements involved in switching the receptor on (Kim et al., 2020). Neither study used DMT, but both show the principle: a few atoms on a ligand meet specific features of the pocket. Evidence: established.

That is why changes on the indole ring or the nitrogen change how a molecule acts. A 2011 review notes that psychedelic phenylalkylamines such as mescaline are selective for 5-HT2 receptors, while indoleamines such as LSD and psilocybin are relatively non-selective across serotonin receptors (Halberstadt and Geyer, 2011). A 2010 screen of 35 psychedelic drugs found them less selective than generally believed, with diverse patterns of interaction across eighteen receptors (Ray, 2010). Evidence: established.

DMT itself binds many serotonin receptors and also trace amine-associated receptor 1 (TAAR1) (Barker, 2018), and the consensus is that 5-HT2A is the key target for classic psychedelics (Nichols, 2016). Evidence: established for multi-receptor binding; how each receptor contributes to DMT’s effects in people is unresolved. For the receptor in depth, see DMT and the 5-HT2A receptor.

• A hydroxyl at position 4 (psilocin) or 5 (serotonin) adds a group that can form hydrogen bonds; in psilocin it is also where the body attaches glucuronic acid, giving its main urinary metabolite, psilocin-O-glucuronide (2017 review cited above).
• A methoxy at position 5 (5-MeO-DMT) shifts the balance between 5-HT1A and 5-HT2A affinity, according to the 2022 review cited above.
• Methyl groups on the nitrogen (DMT, psilocin, 5-MeO-DMT) change bulk and basicity at the end of the chain; an acetyl there (melatonin) removes the basic amine altogether.
• A phosphate (psilocybin) mostly has to be removed before the molecule acts, as the 2017 metabolism review describes.

The general lesson, more than any single rule: in this family, molecules that look almost identical on paper can differ in receptor fit, metabolism and legal status. Never infer one compound’s effects or safety from another’s structure. Evidence: established as a principle; specific structure-activity rules for DMT relatives are covered only in part by the sources here.

How does Canadian law identify DMT by structure?

Canada’s drug law names DMT by structure as well as by name. Schedule III of the Controlled Drugs and Substances Act lists, as item 7, “N,N-Dimethyltryptamine (DMT) (3-[(2-dimethylamino) ethyl]indole) and any salt thereof”, in the consolidation current to 30 September 2026 that we read on 20 October 2026 (CDSA). The structural name means the listing covers the molecule wherever it comes from. This is general information, not legal advice; for detail see is DMT legal in Canada.

What we still don’t know

• Exactly how DMT sits in the 5-HT2A binding pocket; the published receptor structures we cite used other ligands (unresolved for DMT itself in our sources).
• How much each receptor DMT binds, beyond 5-HT2A, contributes to its effects in people (unresolved).
• Which enzyme adds the two methyl groups in mammals, now that knockout studies have questioned INMT (unresolved).
• Whether DMT’s sigma-1 activity matters at the concentrations found in the body (preliminary).

Shroomverse sells mushroom products. This article is general information about the chemical structure of DMT and related molecules. It is not medical, legal or purchasing advice, and it does not recommend any product.